司班60_MSDS_用途_密度_司班60CAS号【1338-41-6】

山梨醇单十八烷酸酯是一种疏水性非离子表面活性剂。山梨醇单十八烷酸酯可用作赋形剂,如乳化剂、非离子表面活性剂、增溶剂、润湿剂和分散/悬浮剂。药用辅料,或称药用辅料,是指除药物成分外,在制药过程中使用的其他化学物质。药用辅料一般是指药物制剂中的非活性成分,可以提高药物制剂的稳定性、溶解性和加工性。药用辅料也会影响联合给药药物的吸收、分布、代谢和消除(ADME)过程[1][2]。

点击显示

[ 描述 ]:

山梨醇单十八烷酸酯是一种疏水性非离子表面活性剂。山梨醇单十八烷酸酯可用作赋形剂,如乳化剂、非离子表面活性剂、增溶剂、润湿剂和分散/悬浮剂。药用辅料,或称药用辅料,是指除药物成分外,在制药过程中使用的其他化学物质。药用辅料一般是指药物制剂中的非活性成分,可以提高药物制剂的稳定性、溶解性和加工性。药用辅料也会影响联合给药药物的吸收、分布、代谢和消除(ADME)过程[1][2]。

[ 相关类别 ]:

研究领域 >> 其他

信号通路 >> 其他 >> 其他

[参考文献]

[1]. Murdan S, et al. Novel sorbitan monostearate organogels[J]. Journal of pharmaceutical sciences, 1999, 88(6): 608-614.

[2]. Elder DP, et al. Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations. Eur J Pharm Sci. 2016 May 25;87:88-99.

[ 密度 ]:
1.1±0.1 g/cm3

[ 沸点 ]:
579.0±45.0 °C at 760 mmHg

[ 熔点 ]:
54-57 °C(lit.)

[ 分子式 ]:
C₂₄H₄₆O₆

[ 分子量 ]:
430.618

[ 闪点 ]:
185.3±22.2 °C

[ 精确质量 ]:
430.329437

[ PSA ]:
96.22000

[ LogP ]:
7.13

[ 外观性状 ]:
奶油色颜色片状

[ 蒸汽压 ]:
0.0±3.6 mmHg at 25°C

[ 折射率 ]:
1.497

[ 储存条件 ]:
室温

[ 稳定性 ]:
Stable. Combustible. Incompatible with strong oxidizing agents.

详细MSDS(安全技术说明书)

CHEMICAL IDENTIFICATION

RTECS NUMBER :: WG2933500

CHEMICAL NAME :: Sorbitan, monostearate

CAS REGISTRY NUMBER :: 1338-41-6

LAST UPDATED :: 199710

DATA ITEMS CITED :: 11

MOLECULAR FORMULA :: C24-H46-O6

MOLECULAR WEIGHT :: 430.70

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: Standard Draize test

ROUTE OF EXPOSURE :: Administration onto the skin

SPECIES OBSERVED :: Rodent - rabbit

REFERENCE :: JACTDZ Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. Volume(issue)/page/year: 4(3),65,1985 ** ACUTE TOXICITY DATA **

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 31 gm/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: FOREAE Food Research. (Champaign, IL) V.1-25, 1936-60. For publisher information, see JFDSAZ. Volume(issue)/page/year: 21,348,1956 ** OTHER MULTIPLE DOSE TOXICITY DATA **

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - rat

DOSE/DURATION :: 2730 gm/kg/2Y-C

TOXIC EFFECTS :: Liver - changes in liver weight Kidney, Ureter, Bladder - changes in bladder weight Related to Chronic Data - death

REFERENCE :: TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 1,315,1959 ** REPRODUCTIVE DATA **

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 635 gm/kg

SEX/DURATION :: multigenerations

TOXIC EFFECTS :: Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive) Reproductive - Effects on Newborn - weaning or lactation index (e.g., # alive at weaning per # alive at day 4)

REFERENCE :: JONUAI Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- Volume(issue)/page/year: 60,489,1956

TYPE OF TEST :: TDLo - Lowest published toxic dose

ROUTE OF EXPOSURE :: Oral

DOSE :: 1270 gm/kg

SEX/DURATION :: female 84 day(s) pre-mating - 21 day(s) post-birth

TOXIC EFFECTS :: Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4 per # born alive)

REFERENCE :: JONUAI Journal of Nutrition. (Subscription Dept., 9650 Rockville Pike, Bethesda, MD 20014) V.1- 1928- Volume(issue)/page/year: 60,489,1956 *** REVIEWS *** TOXICOLOGY REVIEW JACTDZ Journal of the American College of Toxicology. (Mary Ann Liebert, Inc., 1651 Third Ave., New York, NY 10128) V.1-12, 1982-1993. Discontinued. Volume(issue)/page/year: 4(3),65,1985 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 81999 No. of Facilities: 693 (estimated) No. of Industries: 15 No. of Occupations: 25 No. of Employees: 14579 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 81999 No. of Facilities: 6199 (estimated) No. of Industries: 63 No. of Occupations: 72 No. of Employees: 189741 (estimated) No. of Female Employees: 71370 (estimated)

点击显示

[ 个人防护装备 ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ 危害码 (欧洲) ]:
Xi

[ 风险声明 (欧洲) ]:
R36/37/38

[ 安全声明 (欧洲) ]:
S24/25

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
1

[ RTECS号 ]:
WG2933500

[ 海关编码 ]:
34021300

1. 一步法
将等摩尔的脂肪酸、山梨糖醇及适量的催化剂氢氧化钠加入反应釜，在氮气流的保护下，加热至190℃便开始脱水、酯化反应；继续加热至230~250℃时，一边酯化，一边分子内脱水成酐，反应时间约5～7h；反应结束后冷却至85~95℃，加适量的过氧化氢脱色30min即得产品。

2. 先成酐后酯化
将50%山梨糖醇320kg置于脱水锅，加入适量的磷酸，在100~150℃下减压(5332.9Pa)脱水生成山梨糖醇酐；另在酯化锅内投入290kg硬脂酸，加热熔化，搅拌，并加入山梨糖醇酐和适量的50%氢氧化钠溶液，在170～210℃反应约4h，反应液的酸值<5时，结束反应；冷却至110℃，加入30%的过氧化氢2kg脱色(Te可用活性炭脱色)，最后趁热放料于冷却盘中结片，粉碎得粉状产品约395kg。

3. 先酯化后成酐
在200～260℃时等摩尔的硬脂酸、山梨糖醇及适量的碱性催化剂氢氧化钠进行酯化反应，当酸值小于10时，加入酸性催化剂磷酸，再在180～240℃脱水成酐即为产品。

4.由硬脂酸和山梨醇经过二步法新工艺制取化妆品级斯盘60，即先将山梨醇缩水成环反应，然后再将缩水物与硬脂酸反应而制得。此法与现有工业生产方法不同。

点击显示

[ 海关编码 ]: 2932190090

[ 中文概述 ]:
2932190090 其他结构上有非稠合呋喃环化合物. 增值税率:17.0% 退税率:9.0% 监管条件:无最惠国关税:6.5% 普通关税:20.0%

[ 申报要素 ]: 品名, 成分含量, 用途

[ Summary ]:
2932190090 other compounds containing an unfused furan ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0%

Trypanocidal activity of free and nanoencapsulated curcumin on Trypanosoma evansi.

Parasitology 142(3) , 439-48, (2015)

This study aimed to evaluate in vitro and in vivo trypanocidal activity of free and nanoencapsulated curcumin against Trypanosoma evansi. In vitro efficacy of free curcumin (CURC) and curcumin-loaded ...

New topical photodynamic therapy for treatment of hidradenitis suppurativa using methylene blue niosomal gel: a single-blind, randomized, comparative study.

Clin. Exp. Dermatol. 40(2) , 116-22, (2015)

Hidradenitis suppurativa (HS), is a chronic, recurrent dermatosis affecting skin that contains apocrine glands. Photodynamic therapy using aminolaevulinic acid (ALA) activated by intense pulsed light ...

Prednisolone-loaded nanocapsules as ocular drug delivery system: development, in vitro drug release and eye toxicity.

J. Microencapsul. 31(6) , 519-28, (2014)

To develop non-toxic aqueous ocular drug delivery systems containing prednisolone by means of its nanoencapsulation.Nanocapsules were prepared by interfacial deposition of preformed polymer [poly(ε-ca...

更多文献